Merck (MRK) could be interested in acquiring Bausch & Lomb, with Merck CEO Kenneth Frazier saying "It's something that's worth thinking about." Any bid for Bausch & Lomb, whose owner, Warburg Pincus, hopes to get at least $10B in a sale, would be something of an about-turn for Frazier, as he previously said Merck isn't interested in large pharmaceuticals acquisitions. (previous)
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Tue, 6:05PM)
at MarketWatch.com (Feb 23, 2015)
at CNBC.com (Feb 4, 2015)
at MarketWatch.com (Feb 2, 2015)
at Nasdaq.com (Jan 27, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs